The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
Open accessAbstract
Long-term diabetes increases the likelihood of developing secondary damage to numerous systems, and these complications represent a substantial cause of morbidity and mortality. Establishing the causes of diabetes remains the key step towards eradicating the disease, but the prevention and amelioration of diabetic complications is equally important for the millions of individuals who already have the disease or are likely to develop it before prophylaxis or a cure become routinely available. In this Review, we focus on four common complications of diabetes, discuss the range of pathologies that are precipitated by hyperglycaemia and highlight emerging targets for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy
Toth, C., Rong, L. L., Yang, C., Martinez, J., Song, F., Ramji, N., Brussee, V., Liu, W., Durand, J., Nguyen, M. D., et al. (2008) · Diabetes · doi:10.2337/db07-0339 · Cited by 187
Self-citationRetracted(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Self-citationIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,802
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38012-9 · Cited by 2,048
Turner, R. D., & Holman, R. R. (1998) · Cited by 1,974
Tepper, O. M., Galiano, R. D., Capla, J. M., Kalka, C., Gagne, P. J., Jacobowitz, G. R., Levine, J. P., & Gurtner, G. C. (2002) · Circulation · doi:10.1161/01.cir.0000039526.42991.93 · Cited by 1,448
Barber, A. J., Lieth, E., Khin, S. A., Antonetti, D. A., Buchanan, A. G., & Gardner, T. W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2425 · Cited by 1,295
Structural-functional relationships in diabetic nephropathy.
Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E., Brown, D. M., & Goetz, F. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111523 · Cited by 1,209
The Prevalence of Diabetic Retinopathy Among Adults in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.552 · Cited by 1,148
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081188 · Cited by 1,115
Self-citationKeech, A., Mitchell, P., Summanen, P., O'Day, J., Davis, T., Moffitt, M., Taskinen, M.-R., Simes, R., Tse, D., Williamson, E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61607-9 · Cited by 1,109
Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,104
Self-citationAmelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103
Self-citationAliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
Parving, H.-H., Persson, F., Lewis, J. B., Lewis, E. J., & Hollenberg, N. K. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708379 · Cited by 1,098
Susztak, K., Raff, A. C., Schiffer, M., & Böttinger, E. P. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0894 · Cited by 1,096
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M.-P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J.-L. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,072
Self-citationAmerican Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s79 · Cited by 1,042
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
Self-citationThe Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy
Mogensen, C. E., Christensen, C. K., & Vittinghus, E. (1983) · Diabetes · doi:10.2337/diab.32.2.s64 · Cited by 967
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Mouse Models of Diabetic Nephropathy
Brosius, F. C., Alpers, C. E., Bottinger, E. P., Breyer, M. D., Coffman, T. M., Gurley, S. B., Harris, R. C., Kakoki, M., Kretzler, M., Leiter, E. H., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070721 · Cited by 895
Frank, R. N. (2004) · New England Journal of Medicine · doi:10.1056/nejmra021678 · Cited by 891
EFNS guidelines on pharmacological treatment of neuropathic pain
Attal, N., Cruccu, G., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T., Sampaio, C., Sindrup, S., & Wiffen, P. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01511.x · Cited by 880
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815 · cited 1×
“Both type 1 (ReFs 4, 5) and type 2 (ReFs 6-8) diabetes have a largely irreversible and devastating effect on small and large blood vessels, and the consequences of vascular injury, such as hypertension, altered vascular permeability and ischaemia, can also contribute to the other complications of diabetes.”
BackgroundFundus Photographic Risk Factors for Progression of Diabetic Retinopathy
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38014-2 · Cited by 814
Long-term follow-up after tight control of blood pressure in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Neil, H. A. W., & Matthews, D. R. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806359 · Cited by 762
The Sorbitol Pathway and the Complications of Diabetes
Steinmetz, P. R., Balko, C., & Gabbay, K. H. (1973) · New England Journal of Medicine · doi:10.1056/nejm197304192881609 · Cited by 759
Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker
Kass, D. A., Shapiro, E. P., Kawaguchi, M., Capriotti, A. R., Scuteri, A., deGroof, R. C., & Lakatta, E. G. (2001) · Circulation · doi:10.1161/hc3801.097806 · Cited by 727
Projecting the Number of Patients with End-Stage Renal Disease in the United States to the Year 2015
Gilbertson, D. T., Liu, J., Xue, J. L., Louis, T. A., Solid, C. A., Ebben, J. P., & Collins, A. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010112 · Cited by 719
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy
Cameron, N. E., Eaton, S. E. M., Cotter, M. A., & Tesfaye, S. (2001) · Diabetologia · doi:10.1007/s001250100001 · Cited by 701
Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy
Lambeth, J. D. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.027 · Cited by 679
Long-term effect of diabetes and its treatment on cognitive function
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa066397 · Cited by 646
Kern, T. S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/95103 · Cited by 614
Self-citationPaget's Disease of the Mandible
Patel, M. B., & Bhalla, A. (2008) · New England Journal of Medicine · doi:10.1056/nejmicm066227 · Cited by 610
Wendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L. L., Moser, B., Markowitz, G. S., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63909-0 · Cited by 600
Self-citationFreynhagen, R., Strojek, K., Griesing, T., Whalen, E., & Balkenohl, M. (2005) · Pain · doi:10.1016/j.pain.2005.02.032 · Cited by 572
EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy
Lauria, G., Cornblath, D. R., Johansson, O., McArthur, J. C., Mellgren, S. I., Nolano, M., Rosenberg, N., & Sommer, C. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01260.x · Cited by 565
Tomlinson, D. R., & Gardiner, N. J. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2294 · Cited by 564
Pathogenesis, prevention, and treatment of diabetic nephropathy
Cooper, M. E. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01346-4 · Cited by 560
Self-citationNissen, S. E. (2005) · JAMA · doi:10.1001/jama.294.20.joc50147 · Cited by 556
Raskin, J., Pritchett, Y. L., Wang, F., D'Souza, D. N., Waninger, A. L., Iyengar, S., & Wernicke, J. F. (2005) · Pain Medicine · doi:10.1111/j.1526-4637.2005.00061.x · Cited by 532
Surrogate Markers of Small Fiber Damage in Human Diabetic Neuropathy
Quattrini, C., Tavakoli, M., Jeziorska, M., Kallinikos, P., Tesfaye, S., Finnigan, J., Marshall, A., Boulton, A. J. M., Efron, N., & Malik, R. A. (2007) · Diabetes · doi:10.2337/db07-0285 · Cited by 515
Collins, R., Armitage, J., Parish, S., Sleight, P., & Peto, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12475-0 · Cited by 492
Progression of Incipient Diabetic Retinopathy During Good Glycemic Control
Engerman, R. L., & Kern, T. S. (1987) · Diabetes · doi:10.2337/diab.36.7.808 · Cited by 490 · cited 1×
“Although it is widely accepted that diabetic retinopathy is caused by poor glycaemic control, the progression of retinopathy does not reverse, or even immediately halt, when better glycaemic control is achieve”
BackgroundSelf-citationThe Ins2AkitaMouse as a Model of Early Retinal Complications in Diabetes
Barber, A. J., Antonetti, D. A., Kern, T. S., Reiter, C. E. N., Soans, R. S., Krady, J. K., Levison, S. W., Gardner, T. W., & Bronson, S. K. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1340 · Cited by 472
Self-citationOldfield, M. D., Bach, L. A., Forbes, J. M., Nikolic-Paterson, D., McRobert, A., Thallas, V., Atkins, R. C., Osicka, T., Jerums, G., & Cooper, M. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11951 · Cited by 472
Self-citationMouse Models of Diabetic Nephropathy
Breyer, M. D., Bo[Combining Diaeresis]ttinger, E., Brosius, F. C., Coffman, T. M., Harris, R. C., Heilig, C. W., & Sharma, K. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080648 · Cited by 467
Turner, R., Cull, C., Holman, R., & United Kingdom Prospective Diabetes Study Group (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-1_part_2-199601011-00011 · Cited by 465
Chaturvedi, N., Porta, M., Klein, R., Orchard, T., Fuller, J., Parving, H. H., Bilous, R., & Sjølie, A. K. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61412-9 · Cited by 451
Sjølie, A. K., Klein, R., Porta, M., Orchard, T., Fuller, J., Parving, H. H., Bilous, R., & Chaturvedi, N. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61411-7 · Cited by 435
Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials
Backonja, M., & Glanzman, R. L. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)90011-7 · Cited by 425
Fadini, G. P., Sartore, S., Albiero, M., Baesso, I., Murphy, E., Menegolo, M., Grego, F., Vigili de Kreutzenberg, S., Tiengo, A., Agostini, C., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000237750.44469.88 · Cited by 421
Villeneuve, L. M., Reddy, M. A., Lanting, L. L., Wang, M., Meng, L., & Natarajan, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803623105 · Cited by 412
Nonalbuminuric Renal Insufficiency in Type 2 Diabetes
MacIsaac, R. J., Tsalamandris, C., Panagiotopoulos, S., Smith, T. J., McNeil, K. J., & Jerums, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.195 · Cited by 411
Soro-Paavonen, A., Watson, A. M. D., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., et al. (2008) · Diabetes · doi:10.2337/db07-1808 · Cited by 407
Self-citationLuo, Z. D., Calcutt, N. A., Higuera, E. S., Valder, C. R., Song, Y.-H., Svensson, C. I., & Myers, R. R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041574 · Cited by 381
Self-citationInteraction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy
Cooper, M. E. (2001) · Diabetologia · doi:10.1007/s001250100000 · Cited by 375
Self-citationKloppenborg, R. P., van den Berg, E., Kappelle, L. J., & Biessels, G. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.049 · Cited by 368
Common pathological processes in Alzheimer disease and type 2 diabetes: A review
Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice
Harja, E., Bu, D.-X., Hudson, B. I., Chang, J. S., Shen, X., Hallam, K., Kalea, A. Z., Lu, Y., Rosario, R. H., Oruganti, S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32703 · Cited by 364
Self-citationRole of Advanced Glycation End Products in Diabetic Nephropathy
Forbes, J. M., Cooper, M. E., Oldfield, M. D., & Thomas, M. C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077413.41276.17 · Cited by 351
Self-citationImmunological mechanisms in the pathogenesis of diabetic retinopathy
Adamis, A. P., & Berman, A. J. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0111-x · Cited by 322
The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes
Tuttle, K. R., Bakris, G. L., Toto, R. D., McGill, J. B., Hu, K., & Anderson, P. W. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2686 · Cited by 300
Zhang, Z., Zhang, Y., Ning, G., Deb, D. K., Kong, J., & Li, Y. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803751105 · Cited by 289
Jolivalt, C. G., Lee, C. A., Beiswenger, K. K., Smith, J. L., Orlov, M., Torrance, M. A., & Masliah, E. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21787 · Cited by 287
Diabetic neuropathy and oxidative stress
Pop-Busui, R., Sima, A., & Stevens, M. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.625 · Cited by 286
Impact of genetic background on nephropathy in diabetic mice
Gurley, S. B., Clare, S. E., Snow, K. P., Hu, A., Meyer, T. W., & Coffman, T. M. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00204.2005 · Cited by 286
Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy
Greene, D. A., Arezzo, J. C., Brown, M. B., & the Zenarestat Study Group (1999) · Neurology · doi:10.1212/wnl.53.3.580 · Cited by 278
Experimental Galactosemia Produces Diabetic-like Retinopathy
Engerman, R. L., & Kern, T. S. (1984) · Diabetes · doi:10.2337/diab.33.1.97 · Cited by 278
Self-citationEffect of Ruboxistaurin on Visual Loss in Patients with Diabetic Retinopathy
(2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.07.032 · Cited by 276
Diabetes-Induced Accelerated Atherosclerosis in Swine
Gerrity, R. G., Natarajan, R., Nadler, J. L., & Kimsey, T. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1654 · Cited by 270
Alzheimer-Like Changes in Rat Models of Spontaneous Diabetes
Li, Z.-G., Zhang, W., & Sima, A. A. F. (2007) · Diabetes · doi:10.2337/db07-0171 · Cited by 265
Chalmers, J., & Cooper, M. E. (2008) · New England Journal of Medicine · doi:10.1056/nejme0807625 · Cited by 263
Self-citationPittenger, G. L., Ray, M., Burcus, N. I., McNulty, P., Basta, B., & Vinik, A. I. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1974 · Cited by 263
Peripheral nerve structure and function in experimental diabetes
Sharma, A. K., & Thomas, P. K. (1974) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(74)90136-1 · Cited by 260
Stirban, A., Negrean, M., Stratmann, B., Gawlowski, T., Horstmann, T., Götting, C., Kleesiek, K., Mueller-Roesel, M., Koschinsky, T., Uribarri, J., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0531 · Cited by 259
Erythropoietin both protects from and reverses experimental diabetic neuropathy
Bianchi, R., Buyukakilli, B., Brines, M., Savino, C., Cavaletti, G., Oggioni, N., Lauria, G., Borgna, M., Lombardi, R., Cimen, B., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307823100 · Cited by 248
Mehra, S., Tavakoli, M., Kallinikos, P. A., Efron, N., Boulton, A. J. M., Augustine, T., & Malik, R. A. (2007) · Diabetes Care · doi:10.2337/dc07-0870 · Cited by 247
Burns, W. C., Twigg, S. M., Forbes, J. M., Pete, J., Tikellis, C., Thallas-Bonke, V., Thomas, M. C., Cooper, M. E., & Kantharidis, P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050525 · Cited by 243
Self-citationEpidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy
Smith, A. G., Ramachandran, P., Tripp, S., & Singleton, J. R. (2001) · Neurology · doi:10.1212/wnl.57.9.1701 · Cited by 235
Renard, C. B., Kramer, F., Johansson, F., Lamharzi, N., Tannock, L. R., von Herrath, M. G., Chait, A., & Bornfeldt, K. (2004) · Journal of Clinical Investigation · doi:10.1172/jci17867 · Cited by 228
A Randomized Trial of Sorbinil, an Aldose Reductase Inhibitor, in Diabetic Retinopathy
(1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070110050024 · Cited by 228
Direct Insulin Signaling of Neurons Reverses Diabetic Neuropathy
Brussee, V., Cunningham, F. A., & Zochodne, D. W. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1824 · Cited by 226
Pirart, J. (1977) · PubMed · Cited by 220
Recipes for Creating Animal Models of Diabetic Cardiovascular Disease
Hsueh, W., Abel, E. D., Breslow, J. L., Maeda, N., Davis, R. C., Fisher, E. A., Dansky, H., McClain, D. A., McIndoe, R., Wassef, M. K., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000266449.37396.1f · Cited by 219
The PKC-DRS Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.7.2188 · Cited by 218
Zieman, S. J., Melenovsky, V., Clattenburg, L., Corretti, M. C., Capriotti, A., Gerstenblith, G., & Kass, D. A. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328013e7dd · Cited by 209
Changes of sodium channel expression in experimental painful diabetic neuropathy
Craner, M. J., Klein, J. P., Renganathan, M., Black, J. A., & Waxman, S. G. (2002) · Annals of Neurology · doi:10.1002/ana.10364 · Cited by 207
The RAGE Axis in Early Diabetic Retinopathy
Barile, G. R., Pachydaki, S. I., Tari, S. R., Lee, S. E., Donmoyer, C. M., Ma, W., Rong, L. L., Buciarelli, L. G., Wendt, T., Ho¨rig, H., et al. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1409 · Cited by 200
Self-citationThe Prevalence of Diabetic Retinopathy Among Adult Type1 Diabetic Persons in the United States
Roy, M. S. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.546 · Cited by 191
Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice
Flyvbjerg, A., Denner, L., Schrijvers, B. F., Tilton, R. G., Mogensen, T. H., Paludan, S. R., & Rasch, R. (2004) · Diabetes · doi:10.2337/diabetes.53.1.166 · Cited by 187
The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer’s Disease
Cole, G. M., & Frautschy, S. A. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2006.08.009 · Cited by 187
Statins and diabetes – Authors' reply
Kearney, P. M., Keech, A., Simes, J., Collins, R., & Baigent, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60761-8 · Cited by 185
ACE2 Deficiency Modifies Renoprotection Afforded by ACE Inhibition in Experimental Diabetes
Tikellis, C., Bialkowski, K., Pete, J., Sheehy, K., Su, Q., Johnston, C., Cooper, M. E., & Thomas, M. C. (2008) · Diabetes · doi:10.2337/db07-1212 · Cited by 182
Self-citationHuang, T.-J., Price, S. A., Chilton, L., Calcutt, N. A., Tomlinson, D. R., Verkhratsky, A., & Fernyhough, P. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2129 · Cited by 180
Self-citationHuman aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice
Vikramadithyan, R. K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24819 · Cited by 176
Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease
Ruberte, J., Ayuso, E., Navarro, M., Carretero, A., Nacher, V., Haurigot, V., George, M., Llombart, C., Casellas, A., Costa, C., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19478 · Cited by 175
Recent Studies of Aldose Reductase Enzyme Inhibition for Diabetic Complications
Suzen, S., & Buyukbingol, E. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457377 · Cited by 171
Early Involvement of the Spinal Cord in Diabetic Peripheral Neuropathy
Selvarajah, D., Wilkinson, I. D., Emery, C. J., Harris, N. D., Shaw, P. J., Witte, D. R., Griffiths, P. D., & Tesfaye, S. (2006) · Diabetes Care · doi:10.2337/dc06-0650 · Cited by 170
Development of Late-Stage Diabetic Nephropathy in OVE26 Diabetic Mice
Zheng, S., Noonan, W. T., Metreveli, N. S., Coventry, S., Kralik, P. M., Carlson, E. C., & Epstein, P. N. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3248 · Cited by 165
Ohno-Matsui, K., Hirose, A., Yamamoto, S., Saikia, J., Okamoto, N., Gehlbach, P., Duh, E. J., Hackett, S., Chang, M., Bok, D., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64891-2 · Cited by 163
Skin biopsy as a diagnostic tool in peripheral neuropathy
Lauria, G., & Devigili, G. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0630 · Cited by 158
Retinopathy in animal models of diabetes
Engerman, R. L., & Kern, T. S. (1995) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610110203 · Cited by 157
Self-citationEffect of Ruboxistaurin in Patients With Diabetic Macular Edema
(2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.3.318 · Cited by 151
Rong, L., Yan, S., Wendt, T., Hans, D., Pachydaki, S. I., Bucciarelli, L. G., Adebayo, A., Qu, W., Lu, Y., Kostov, K., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-1900com · Cited by 148
Self-citationHerold, K. C., Moser, B., Chen, Y., Zeng, S., Yan, S. F., Ramasamy, R., Emond, J. C., Clynes, R., & Schmidt, A. M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1206751 · Cited by 146
Self-citationImmunohistochemical Localization of Aldose Reductase: II. Rat Eye and Kidney
Ludvigson, M. A., & Sorenson, R. L. (1980) · Diabetes · doi:10.2337/diab.29.6.450 · Cited by 146
Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
Robison, W. G., Nagata, M., Laver, N., Hohman, T. C., & Kinoshita, J. H. (1989) · PubMed · Cited by 144
Pkc-Drs, G. B. (2005) · Clinical Diabetology · Cited by 144
Effects of Aspirin Treatment on Diabetic Retionopathy
* (1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38010-5 · Cited by 144
Ocular Neovascularization: Basic Mechanisms and Therapeutic Advances
Dorrell, M. I., Uusitalo‐Järvinen, H., Aguilar, E., & Friedlander, M. (2007) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.10.017 · Cited by 140
Interactions between Renin Angiotensin System and Advanced Glycation in the Kidney
Thomas, M. C., Tikellis, C., Burns, W. M., Bialkowski, K., Cao, Z., Coughlan, M. T., Jandeleit-Dahm, K. A. M., Cooper, M. E., & Forbes, J. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010013 · Cited by 136
Self-citationInsulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms
Sugimoto, K., Murakawa, Y., Zhang, W., Xu, G. G., & Sima, A. A. F. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200009/10)16:5<354::aid-dmrr149>3.0.co;2-h · Cited by 135
Riaz, S. S., Malcangio, M., Miller, M., & Tomlinson, D. R. (1999) · Diabetologia · doi:10.1007/s001250051443 · Cited by 129
Central role for aldose reductase pathway in myocardial ischemic injury
Hwang, Y. C., Kaneko, M., Bakr, S. A., Liao, H., Lu, Y., Lewis, E., Yan, S.-D., Ii, S., Itakura, M., Liu, R., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1400com · Cited by 129
Self-citationBril, V., Buchanan, R. A., & the Ranirestat Study Group* (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1447 · Cited by 128
Goss, J. R., Goins, W. F., Lacomis, D., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2227 · Cited by 126
Calkin, A. C., Forbes, J. M., Smith, C. M., Lassila, M., Cooper, M. E., Jandeleit-Dahm, K. A. M., & Allen, T. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000177813.99577.6b · Cited by 126
Self-citationMicrocirculation and oxidative stress
Crimi, E., Ignarro, L. J., & Claudio Napoli, A. (2007) · Free Radical Research · doi:10.1080/10715760701732830 · Cited by 123
Endothelial Cell Activation in Patients With Decompensated Heart Failure
Colombo, P. C., Banchs, J. E., Celaj, S., Talreja, A., Lachmann, J. S., Malla, S., Dubois, N. B., Ashton, A. W., Latif, F., Jorde, U. P., et al. (2004) · Circulation · doi:10.1161/01.cir.0000151611.89232.3b · Cited by 122
Antagonism of RAGE suppresses peripheral nerve regeneration
Rong, L., Trojaborg, W., Qu, W., Kostov, K., Yan, S. D., Gooch, C. L., Szabolcs, M. J., Hays, A. P., & Schmidt, A. M. (2004) · The FASEB Journal · doi:10.1096/fj.04-1899com · Cited by 120
Self-citationOtu, H. H., Can, H., Spentzos, D., Nelson, R. G., Hanson, R. L., Looker, H. C., Knowler, W. C., Monroy, M., Libermann, T. A., Karumanchi, S. A., et al. (2007) · Diabetes Care · doi:10.2337/dc06-1656 · Cited by 117
Diabetes Mellitus in Children and Adolescents
Botero, D., & Wolfsdorf, J. I. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2004.12.002 · Cited by 117
Dale, A. C., VATTEN, L. J., Nilsen, T. I. L., Midthjell, K., & Wiseth, R. (2008) · BMJ · doi:10.1136/bmj.39582.447998.be · Cited by 116
Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs
Engerman, R. L., Kern, T. S., & Larson, M. E. (1994) · Diabetologia · doi:10.1007/s001250050084 · Cited by 111
Self-citationAnimal models of oxygen-induced retinopathy
Penn, J. S. (2003) · Frontiers in bioscience · doi:10.2741/1056 · Cited by 111
Patterns of ischemia in diabetic retinopathy.
Bresnick, G. H., Engerman, R. L., Davis, de Venecia, G., & Fl, M. (1976) · PubMed · Cited by 108
Distal Degenerative Sensory Neuropathy in a Long-Term Type 2 Diabetes Rat Model
Brussee, V., Guo, G., Dong, Y., Cheng, C., Martínez, J. A., Smith, D. R., Glazner, G. W., Fernyhough, P., & Zochodne, D. W. (2008) · Diabetes · doi:10.2337/db07-1737 · Cited by 106
Chronic Vascular Inflammation in Patients With Type 2 Diabetes
Feng, L., Matsumoto, C., Schwartz, A. B., Schmidt, A. M., Stern, D. M., & Pile‐Spellman, J. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.379 · Cited by 103
Self-citationUpregulation of RAGE and its ligands in proliferative retinal disease
Pachydaki, S. I., Tari, S. R., Lee, S. E., Ma, W., Tseng, J., Sosunov, A. A., Cataldergirmen, G., Scarmeas, N., Caspersen, C. S., Chang, S., et al. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.09.022 · Cited by 103
Self-citationParé, M., Albrecht, P. J., Noto, C. J., Bodkin, N. L., Pittenger, G. L., Schreyer, D. J., Tigno, X. T., HANSEN, B. C., & Rice, F. L. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21262 · Cited by 101
A Mouse Model of Diabetic Retinopathy
Kern, T. S. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140194013 · Cited by 101
Self-citationAlteration of the Blood-Retinal Barrier in Experimental Diabetes Mellitus
Waltman, S. R., Krupin, T., Hanish, S. J., Oestrich, C., & Becker, B. (1978) · Archives of Ophthalmology · doi:10.1001/archopht.1978.03910050480018 · Cited by 97
The Renin-Angiotensin System Influences Ocular Endothelial Cell Proliferation in Diabetes
Moravski, C. J., Skinner, S. L., Stubbs, A. J., Sarlos, S., Kelly, D. J., Cooper, M. E., Gilbert, R. E., & Wilkinson‐Berka, J. L. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63806-0 · Cited by 96
Self-citationLessons from UK prospective diabetes study
Turner, R. C., & Holman, R. R. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01105-m · Cited by 94
How Long Should Insulin Be Used Once a Vial Is Started?
Molitch, M. E. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1240-a · Cited by 90
Davis, M. D., Sheetz, M. J., Aiello, L. P., Milton, R. C., Danis, R. P., Zhi, X., Girach, A., Jiménez, M. C. H., & Vignati, L. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2473 · Cited by 88
UK Prospective Diabetes Study Group (1993) · Diabetologia · doi:10.1007/bf02374494 · Cited by 88
Pathogenesis of Spinally Mediated Hyperalgesia in Diabetes
Ramos, K. M., Jiang, Y., Svensson, C. I., & Calcutt, N. A. (2007) · Diabetes · doi:10.2337/db06-1269 · Cited by 84
Self-citationThe effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy
Hoybergs, Y. M. J. J., & Meert, T. F. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.087 · Cited by 81
Kamiya, H., Zhang, W., & Sima, A. A. F. (2006) · Diabetologia · doi:10.1007/s00125-006-0379-0 · Cited by 79
Johansson, F., Kramer, F., Barnhart, S., Kanter, J. E., Vaisar, T., Merrill, R. D., Geng, L. N., Oka, K., Chan, L., Chait, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709958105 · Cited by 77
Pradat, P., Kennel, P., Naimi-Sadaoui, S., Finiels, F., Orsini, C., Revah, F., Delaère, P., & Mallet, J. J. (2001) · Human Gene Therapy · doi:10.1089/10430340152710577 · Cited by 77
RAGE, Diabetes, and the Nervous System
Toth, C. C., Martínez, J. L., & Zochodne, D. W. (2007) · Current Molecular Medicine · doi:10.2174/156652407783220705 · Cited by 77
Cull, C. A., Manley, S. E., Frighi, V., et al. (1993) · Diabetologia · Cited by 77
Comparable myelinated nerve pathology in feline and human diabetes mellitus
Mizisin, A. P., Nelson, R. W., Sturges, B. K., Vernau, K. M., LeCouteur, R. A., Williams, D. C., Burgers, M. L., & Shelton, G. D. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0163-8 · Cited by 75
Microvascular Disease in Type 1 Diabetes Alters Brain Activation
Wessels, A. M., Rombouts, S. A. R. B., Şimşek, S., Kuijer, J. P. A., Kostense, P. J., Barkhof, F., Scheltens, P., Snoek, F. J., & Heine, R. J. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0680 · Cited by 75
Pierson, C. R., Zhang, W., Murakawa, Y., & Sima, A. A. F. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.3.260 · Cited by 74
Starita, C., Patel, M., Katz, B., & Adamis, A. P. (2007) · KARGER eBooks · doi:10.1159/000098504 · Cited by 73
Chattopadhyay, M., Krisky, D. M., Wolfe, D. P., Jc, G., Mata, M. M., & Dj, F. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302533 · Cited by 73
Growth Factors as Therapeutics for Diabetic Neuropathy
Calcutt, N. A., Jolivalt, C. G., & Fernyhough, P. (2008) · Current Drug Targets · doi:10.2174/138945008783431727 · Cited by 65
Self-citationJacobson, P. (2007) · New England Journal of Medicine · doi:10.1056/nejmbkrev57613 · Cited by 64
Joy, S. V., Scates, A. C., Bearelly, S., Dar, M. S., Taulien, C. A., Goebel, J. A., & Cooney, M. J. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e572 · Cited by 60
Price, S. A., Dent, C. L., Duran-Jimenez, B., Liang, Y., Zhang, L., Rebar, E. J., Case, C. C., Gregory, P. D., Martin, T. J., Spratt, S. K., et al. (2006) · Diabetes · doi:10.2337/db05-1060 · Cited by 60
Laser Treatment in Diabetic Retinopathy
Neubauer, A. S., & ULBIG, M. W. (2007) · Ophthalmologica · doi:10.1159/000098254 · Cited by 59
Endoneurial microvascular pathology in feline diabetic neuropathy
Estrella, J. S., Nelson, R. N., Sturges, B. K., Vernau, K. M., Williams, D. C., LeCouteur, R. A., Shelton, G. D., & Mizisin, A. P. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.12.002 · Cited by 56
The pathological interaction between diabetes and presymptomatic Alzheimer's disease
Burdo, J. R., Chen, Q., Calcutt, N. A., & Schubert, D. A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.010 · Cited by 55
Self-citationSuzuki, T., Sekido, H., Kato, N., Nakayama, Y., & Yabe‐Nishimura, C. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02824.x · Cited by 51
Impaired Apparent Ion Demand in Experimental Diabetic Retinopathy: Correction by Lipoic Acid
Berkowitz, B. A., Roberts, R., Stemmler, A. J., Luan, H., & Gradianu, M. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0433 · Cited by 51
Clinical safety of the selective PKC-β inhibitor, ruboxistaurin
McGill, J. B., King, G. L., Berg, P. H., Price, K. L., Kles, K. A., Bastyr, E. J., & Hyslop, D. L. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.6.835 · Cited by 48
Gälman, C., Matasconi, M., Persson, L., Parini, P., Angelin, B., & Rudling, M. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00166.2007 · Cited by 47
Chen, Y. S., Chung, S. S. M., & Chung, S. K. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3112 · Cited by 46
Mechanisms of kidney fibrosis and the role of antifibrotic therapies
Deelman, L., & Sharma, K. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32831c50a1 · Cited by 45
Kato, N., Nemoto, K., Nakanishi, K., Morishita, R., Kaneda, Y., Uenoyama, M., Ikeda, T., & Fujikawa, K. (2005) · Diabetes · doi:10.2337/diabetes.54.3.846 · Cited by 42
Statins for Diabetic Cardiovascular Complications
Ludwig, S. M., & Shen, G. X. (2006) · Current Vascular Pharmacology · doi:10.2174/157016106777698388 · Cited by 37
HSV-1-mediated NGF delivery delays nociceptive deficits in a genetic model of diabetic neuropathy
Walwyn, W. M., Matsuka, Y., Arai, D., Bloom, D. C., Lam, H., Tran, C., Spigelman, I., & Maidment, N. T. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.006 · Cited by 34
Kakinoki, B., Sekimoto, S., Yuki, S., Ohgami, T., Sejima, M., Yamagami, K., & Saito, K.-I. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1091 · Cited by 33
Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients
Panunti, B. A., & Fonseca, V. A. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2005.11.013 · Cited by 30
Clarkson, T. B., Koritnik, D. R., Weingand, K. W., & Miller, L. C. (1985) · Metabolism · doi:10.1016/s0026-0495(85)80010-x · Cited by 29
Jolivalt, C. G., Jiang, Y., Freshwater, J. D., Bartoszyk, G. D., & Calcutt, N. A. (2006) · Diabetologia · doi:10.1007/s00125-006-0397-y · Cited by 29
Self-citationRuessmann, H. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.02.002 · Cited by 26
Animal Models of Diabetic Retinopathy
Kern, T. S. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6780-8_4 · Cited by 23
Self-citationDiabetic Management in Patients with Renal Failure
Amico, J. A., & Klein, I. L. (1981) · Diabetes Care · doi:10.2337/diacare.4.3.430 · Cited by 23
Bakris, G. L., Whelton, P. K., Weir, M. A., Mimran, A., Keane, W. F., & Schiffrin, E. L. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022009549 · Cited by 17
Ratner, R. E., Cannon, C. P., Gerstein, H. C., Nesto, R. W., Serruys, P. W. J. C., van Es, G., Kolatkar, N. S., Kravitz, B. G., Zalewski, A. A., & Fitzgerald, P. J. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.07.025 · Cited by 17
An Epigenetic Clue to Diabetic Vascular Disease
Mack, C. P. (2008) · Circulation Research · doi:10.1161/circresaha.108.184358 · Cited by 14
Cited by
The progress in understanding and treatment of diabetic retinopathy
Stitt, A. W., Curtis, T. M., Chen, M., Medina, R. J., McKay, G. J., Jenkins, A., Gardiner, T. A., Lyons, T. J., Hammes, H.-P., Simó, R., et al. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.08.001 · Cited by 1,164
Molecular pathways associated with oxidative stress in diabetes mellitus
Ighodaro, O. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.058 · Cited by 555
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010) · Circulation Research · doi:10.1161/circresaha.109.212217 · Cited by 381
Self-citationTargeting hepatic glucose metabolism in the treatment of type 2 diabetes
Rines, A. K., Sharabi, K., Tavares, C. D. J., & Puigserver, P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.151 · Cited by 375
Metadata
- Authors
- Calcutt, N. A., Cooper, M. E., Kern, T. S., & Schmidt, A. M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-05
- Volume
- 8
- Issue
- 5
- Pages
- 417-430
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2040766716
- Cited by
- 352
- References
- 201
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.